Insulin aspart, recombinant Subcutaneous and Tetracycline Topical application
Determining the interaction of Insulin aspart, recombinant Subcutaneous and Tetracycline Topical application and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
Generic Name: tetracycline topical
Brand name:
Synonyms: Tetracycline (Topical application)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin aspart, recombinant Subcutaneous-Tetrahydrozoline (Nasal)
- Insulin aspart, recombinant Subcutaneous-Tetrahydrozoline and zinc ophthalmic
- Insulin aspart, recombinant Subcutaneous-Tetrahydrozoline Hydrochloride
- Insulin aspart, recombinant Subcutaneous-Tetrahydrozoline ophthalmic
- Insulin aspart, recombinant Subcutaneous-Tetrofosmin
- Insulin aspart, recombinant Subcutaneous-Tetterine
- Tetracycline Topical application-Insulin degludec
- Tetracycline Topical application-Insulin Degludec (U-100) Prefilled Pens
- Tetracycline Topical application-Insulin Degludec (U-100) Vials
- Tetracycline Topical application-Insulin Degludec (U-200) Prefilled Pens
- Tetracycline Topical application-Insulin degludec and liraglutide
- Tetracycline Topical application-Insulin degludec and liraglutide Subcutaneous